ArticleFrontiers in neurology2024

Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial.

Suzanne Braniecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.